TME Pharma publishes its semi annual results and half-year report Berlin, Germany, October 30, 2025, 21.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology ...
Realty Income (NYSE:O) priced a public offering of $600M of 5.125% senior unsecured notes due 2035. The public offering price for the notes was 98.371% of the principal amount, for an effective ...